HCG4P3: A Pseudogene Encoding for A Protein Involved in The Human Immune System

Target Name: HCG4P3

NCBI ID: G353001

HCG4P3

Other Name(s): HLA complex group 4 pseudogene 3 | HCGIV-03 pseudogene | HCGIV.2 | HCGIV-03 | HCGIV-3

HCG4P3: A Pseudogene Encoding for A Protein Involved in The Human Immune System

HCG4P3 (HLA complex group 4 pseudogene 3) is a non-coding RNA molecule that is expressed in various tissues and cell types throughout the body. It is a part of the human immune system and plays a crucial role in the regulation of immune responses and cell-to-cell interactions.HCG4P3 is also known as HLAP4, and it is coded by the HLA-DP gene.

HLA (Human Leucocyte Antigen) is a family of genes that encode for proteins involved in the immune response. These proteins are highly conserved across different species and are involved in the recognition of foreign antigens by T cells and other immune cells. HLA genes are classified into different classes based on their gene expression pattern, and HLA-DP is one of the major classes.

Pseudogenes are genomic regions that are present in a gene but do not code for any functional RNA molecule. HCG4P3 is a pseudogene that is located in the HLA-DP gene on chromosome 6p21. It is a small gene that encodes for a protein that is similar to other proteins in the HLA family, but its function and expression pattern are not well understood.

HCG4P3 is expressed in various tissues and cell types throughout the body, including the blood, spleen, thymus, lung, liver, and gut. It is also expressed in the placenta, which is a vital organ that plays a critical role in the development and maintenance of the immune system.

One of the interesting aspects of HCG4P3 is its expression pattern. It is mainly expressed in the cytoplasm of various cell types, including T cells, B cells, and macrophages. It is also expressed in the endoplasmic reticulum (ER) and the nuclear envelope ( NE), which suggests that it may be involved in the regulation of intracellular signaling pathways.

Another potential mechanism by which HCG4P3 may be involved in immune responses is its role in the regulation of T cell development. T cells are a crucial part of the immune system, and they play a critical role in protecting the body against infection and disease. HCG4P3 has been shown to be involved in the regulation of T cell development by regulating the expression of several genes involved in the T cell receptor (TCR) signaling pathway.

HCG4P3 has also been shown to be involved in the regulation of cell-to-cell interactions between immune cells. It has been shown to be involved in the regulation of expression of adhesion molecules, which is important for the regulation of immune cell interactions and the development of immune tolerance.

In addition to its potential role in immune regulation, HCG4P3 may also be involved in other cellular processes. It has been shown to be involved in the regulation of cell cycle progression, and it has been shown to be involved in the regulation of apoptosis, which is a critical process that helps cells eliminate themselves when they are no longer needed.

In conclusion, HCG4P3 is a non-coding RNA molecule that is expressed in various tissues and cell types throughout the body. It is a part of the human immune system and plays a crucial role in the regulation of immune responses and cell-to-cell interactions. Further research is needed to understand the full function and regulation of HCG4P3 and its potential as a drug target or biomarker.

Protein Name: HLA Complex Group 4 Pseudogene 3

The "HCG4P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HCG4P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets